The vote was 89-3 on the motion to end debate on the Food and Drug Administration Safety and Innovation ACt (S. 3187).

A week earlier the House approved the bill and sent the amended version back to the Senate.

The legislation reauthorizes certain FDA programs and expands a user-fee program in order to speed up the FDA's approval process for certain drug and medical device applications.

Sens. Richard BurrRichard BurrTrump's pick for intel chief to get hearing next week A guide to the committees: Senate Juan Williams: Senate GOP begins to push Trump away MORE (R-N.C.), Rand PaulRand PaulConquering Trump returns to conservative summit Rand Paul rejects label of 'Trump's most loyal stooge' GOP healthcare plans push health savings account expansion MORE (R-Ky.) and Bernie SandersBernie SandersSanders on Trump's media attacks: He doesn't understand democracy Drug importation won't save dollars or lives Dems fear divisions will persist after DNC chair election MORE (I-Vt.) voted against the motion to end debate.